Probably not a good way to phrase it. But from the statements these three patients had recurrent aortic stenosis with ischaemic heart disease and the company's valve was deemed the best option to improve haemodynamic function while allowing or preserving coronary artery catherter access. That's a pretty good endorsement considering the number of existing competitors with approval.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)